From Concept to Market

From Concept to Market
Home / Technology / From Concept to Market

From Concept to Market

We offer the following significant opportunities for the biopharmaceutical industry:

  • Broad range of expression capabilities. ProCellEx® is able to produce a broad array of complex glycosylated proteins, some of which are difficult to produce in mammalian, bacterial and  and yeast cell-based systems.
  • Significantly lower capital and production costs.
  • Rapid scalable manufacturing based on requirements. Elimination of risk of mammalian viral transmission or infection.
  • Biologic Optimization: ProCellEx® has internal capabilities developed to improve the biologic dynamics of an expressed protein, and thus to develop modified therapeutic proteins with potentially superior clinical profiles.
  • Opportunities to penetrate patent-protected markets.
  • Potential ability to administer active therapeutic enzymes orally.
  • In-house capabilities for clinical development and regulatory affairs.

From Concept to Market

step1-new Selecting the target protein-drug candidate
step2-new Gene of interest engineering
Plant cells are genetically engineered to express the gene of interest
step3-new2 Protein drug enhancement modifications
Improving biological dynamics to bring forth improved clinical profiles
step4-new Pilot production with the ProCellEx® Platform
Isolation and Purification for parentally delivered and inhaled  biopharmaceuticals
Isolation of intact plant cells for orally delivered products
 step6-new Product development
Clinical development and regulatory activity
step5-new Commercial production
Scaling up the cell suspension to produce commercial amounts of the target protein